Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF)... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RSSE | 24.32 | 0.30 | +1.24% |
| FT Vest U.S. Equity Equal Weight Buffer ETF - September (RSSE) | |||
| DFEV | 39.50 | 0.25 | +0.64% |
| Dimensional Emerging Markets Value ETF (DFEV) | |||
| NBFC | 49.48 | 0.24 | +0.49% |
| Neuberger Flexible Credit Income ETF (NBFC) | |||
| IGHG | 77.03 | 0.16 | +0.21% |
| ProShares Investment Grade-Interest Rate Hedged (IGHG) | |||
| OBOR | 26.00 | N/A | N/A |
| KraneShares MSCI One Belt One Road Index ETF (OBOR) | |||
Industry Biotechnology